DAVID
BERNARDO ORDIZ
PROFESORA SUSTITUTA/PROFESOR SUSTITUTO
![Foto de DAVID](/img/nophoto.png)
![Foto de Hospital de Fuenlabrada](/img/noimage_org.png)
Hospital de Fuenlabrada
Fuenlabrada, EspañaPublicacións en colaboración con investigadores/as de Hospital de Fuenlabrada (4)
2020
-
Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's disease
European Journal of Gastroenterology and Hepatology, Vol. 32, Núm. 5, pp. 588-596
2019
-
Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients
Digestive Diseases and Sciences, Vol. 64, Núm. 3, pp. 846-854
-
Effectiveness and safety of the switch from remicade® to CT-P13 in patients with inflammatory bowel disease
Journal of Crohn's and Colitis, Vol. 13, Núm. 11, pp. 1380-1386
-
Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease
Therapeutic Advances in Gastroenterology, Vol. 12